IMARA Inc. Uncategorized Contracts & Agreements
13 Contracts & Agreements
- Description of the Registrants Securities (Filed With SEC on March 14, 2024)
- Open Market Sale AgreementSM, dated June 23, 2023, by and between Enliven Therapeutics, Inc. and Jefferies LLC (Filed With SEC on June 26, 2023)
- Amended and Restated 2020 Plan (Filed With SEC on March 1, 2023)
- Contingent Value Rights Agreement between the Company and Rights Agent (Filed With SEC on March 1, 2023)
- Letter Agreement, dated as of January 27, 2023, by and among the Registrant, Rahul Ballal, Michael Gray and Enliven Therapeutics, Inc (Filed With SEC on February 10, 2023)
- First Amendment to the Letter Agreement, dated as of November 5, 2021, by and between the Registrant and Kenneth M. Attie, M.D (Filed With SEC on March 15, 2022)
- Letter Agreement, dated as of December 4, 2020, by and between the Registrant and Kenneth M. Attie, M.D (Filed With SEC on March 15, 2022)
- First Amendment to the Amended and Restated Letter Agreement, dated as of November 5, 2021, by and between the Registrant and Michael P. Gray (Filed With SEC on November 9, 2021)
- First Amendment to the Amended and Restated Letter Agreement, dated as of November 5, 2021, by and between the Registrant and Rahul D. Ballal, Ph.D (Filed With SEC on November 9, 2021)
- Description of Securities of the Registrant (Filed With SEC on March 5, 2021)
- Amended and Restated Letter Agreement, dated as of September 23, 2019, by and between the Registrant and Michael P. Gray (Filed With SEC on February 14, 2020)
- Amended and Restated Letter Agreement, dated as of September 23, 2019, by and between the Registrant and Willem H. Scheele, M.D (Filed With SEC on February 14, 2020)
- Amended and Restated Letter Agreement, dated as of September 23, 2019, by and between the Registrant and Rahul D. Ballal, Ph.D (Filed With SEC on February 14, 2020)
